¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cyclic compound"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • asymmetric compound
    ºñ´ëĪȭÇÕ¹°
  • acyclic compound
    ¹«°í¸®È­ÇÕ¹°
  • addition compound
    ÷°¡È­ÇÕ¹°
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°
  • amphoteric compound
    ¾ç¼ºÈ­ÇÕ¹°
  • closed-chain compound
    ´ÝÈù»ç½½È­ÇÕ¹°
  • complex compound
    º¹ÇÕÈ­ÇÕ¹°
  • compound
    1. È­ÇÕ¹° 2. º¹ÇÕ
  • compound astigmatism
    º¹ÇÕ³­½Ã
  • compound dislocation
    º¹ÀâÅ»±¸
  • compound fracture
    º¹ÇÕ°ñÀý, °³¹æ°ñÀý
  • compound gland
    º¹ÇÕ»ù, º¹ÇÕ¼±
  • compound heterozygote
    º¹ÇÕÀÌÇüÁ¢ÇÕÀÚ
  • compound joint
    º¹ÇÕ°üÀý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acyclic compound
    ¹«°í¸®È­ÇÕ¹°
  • addition compound
    ÷°¡È­ÇÕ¹°
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°
  • amphoteric compound
    ¾ç¼ºÈ­ÇÕ¹°
  • aromatic compound
    ¹æÇâÁ·È­ÇÕ¹°
  • asymmetric compound
    ºñ´ëĪȭÇÕ¹°
  • compound astigmatism
    º¹ÇÕ³­½Ã
  • compound
    º¹Àâ, º¹ÇÕ, È­ÇÕ¹°
  • chain compound
    »ç½½È­ÇÕ¹°
  • complex compound
    º¹ÇÕÈ­ÇÕ¹°
  • compound dislocation
    º¹ÀâÅ»±¸
  • compound fracture
    º¹Àâ°ñÀý, °³¹æ°ñÀý
  • compound gland
    º¹ÇÕ»ù
  • compound joint
    º¹ÇÕ°üÀý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inorganic compound
    ¹«±âÈ­ÇÕ¹°.
  • polyfunctional compound
    ´Ù°ü´ÉÈ­ÇÕ¹°(ÒýίÒöûùùêÚª).
  • quaternary compound
    »ç¿øÈ­ÇÕ¹°(ÞÌêªûùùêÚª).
  • racemic compound
    ·¹À̼¼¹ÌÈ­ÇÕ¹°.
  • radioactive luminous compound
    ¹æ»ç¼º¹ß±¤È­ÇÕ¹°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cyclic headache
    Áֱ⼺ µÎÅë(ñÎÑ¢àõÔé÷Ô).
  • cyclic hematopoiesis
  • cyclic hemorrhage
    Áֱ⼺ ÃâÇ÷(¡­õóúì).
  • cyclic hydrocarbon
    °í¸®Çü źȭ¼ö¼Ò(¡­÷©ûùâ©áÈ).
  • cyclic neutropenia
    Áֱ⼺ È£Áß±¸°¨¼ÒÁõ(¡­û¿ñéϹÊõá´ñø).
  • cyclic neutropenia
    Áֱ⼺ È£Áß±¸°¨¼ÒÁõ(?̴̡˴˧ËÛÌ¡).
  • cyclic parturition
    Áֱ⼺ ºÐ¸¸.
  • cyclic periodicity
    ¼øÈ¯Áֱ⼺.
  • cyclic spasm
    Áֱ⿬Ãà
  • cyclic strabismus
    ÁÖ±â»ç½Ã
  • cyclic vomiting
    ÁÖ±â(¼º) ±¸Åä(Áõ) ¾Æ¼¼ÅæÇ÷¼º ±¸ÅäÁõ .
  • cyclic vomiting
    ÁÖ±â(¼º) ±¸Åä(Áõ) ¾Æ¼¼ÅæÇ÷¼º ±¸ÅäÁõ .
  • cyclic<³ª> cyclicus
    ÁÖ±â(¼º)(ñÎÑ¢àõ)ÀÇ, ¼øÈ¯(âàü»)ÀÇ, °í¸®ÀÇ.
  • idiopathic cyclic edema
    Ư¹ß¼º Áֱ⼺ ºÎÁ¾.
  • schizophrenia, cyclic
    ¼øÈ¯Çü Á¤½ÅºÐ¿­º´
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • azo compound
    ¾ÆÁ¶È­ÇÕ¹°(ûùùêÚª)
  • carbamino compound
    Ä«¸£¹Ù¸¶À̵å È­ÇÕ¹°(ûùùêÚª)
  • compound
    È­ÇÕ¹°(ûùùêÚª)
  • compound lipid
    "È­ÇÕÁöÁú(ûùùêò·òõ), (ÔÒ) complex lipid"
  • compound microscope
    º¹ÇÕÇö¹Ì°æ(ÜÜùêúéÚ°Ìð)
  • diazo compound
    µð¾ÆÁ¶ È­ÇÕ¹°(ûùùêÚª)
  • diazonium compound
    µð¾ÆÁ¶´½ È­ÇÕ¹°(ûùùêÚª) (ÔÒ) diazonium salt
  • energy-poor compound
    ºó(Þ¸)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • energy-rich compound
    ºÎ(Ý£)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • enzyme-substrate compound
    È¿¼Ò-±âÁú È­ÇÕ¹° (ý£áÈÐñòõûùùêÚª)
  • high-energy compound
    °í(ÍÔ)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • Kendall's compound
    ÄË´Þ È­ÇÕ¹°(ûùùêÚª)
  • labeled compound
    Ç¥ÁöÈ­ÇÕ¹°(øöò½ûùùêÚª)
  • low-energy compound
    Àú(î¸)¿¡³ÊÁöÈ­ÇÕ¹°(ûùùêÚª)
  • meso compound
    ¸Þ¼ÒÈ­ÇÕ¹°(ûùùêÚª)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CAMP Christie-Atkins-Munch-Petersen [test]; computer-assisted menu planning; concentration of adenosine m...
cAMP cyclic adenosine monophosphate
CCP cephalin-cholesterol flocculation; ciliocytophthoria; chronic calcifying pancreatitis; community car...
CCT carotid compression tomography; central conduction time; cerebrocranial trauma; chocolate-coated tab...
cGMP cyclic guanosine monophosphate
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
cyclic GMP Cyclic guanosine monophosphate
C 48/80 Compound 48/80
CAP Compound Action Potential
CMAP Compound motor action potential
CMAP Compound muscle action potential
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • compound anchorage
    º¹ÇÕ °íÁ¤
    µÎ °³ ȤÀº ±× ÀÌ»óÀÇ Ä¡¾Æ·ÎºÎÅÍ ÀúÇ×À» ¹Þ´Â ±³Á¤ °íÁ¤.
  • compound cavity
    º¹ÇÕ ¿Íµ¿
    óġµÈ »óÅ¿¡¼­ Ä¡¾ÆÀÇ 2¸éÀÌ Ä§½ÀµÈ ¿ì½Ä º´¼Ò.
  • compound composite odontoma
    º¹ÇÕ¼º Ä¡¾ÆÁ¾, ÁýÇÕ¼º Ä¡¾ÆÁ¾
  • compound dislocation
    º¹Àâ Å»±¸
  • compound gland
    º¹ÇÕ »ù, º¹ÇÕ¼±
    ºÐºñ °üÀÌ °¡Áö¸¦ ³½´Ù. ºÐºñ ´ÜÀ§´Â È¥ÇÕÇüÀ¸·Î, °ü»ó Æ÷»ó »ùÀ̶ó´Â ¿ë¾î°¡ »ç¿ëµÈ´Ù.
  • compound nevus
    º¹ÇÕ¼º ¸ð¹Ý, º¹ÇÕ ¸ð¹Ý
  • compound S
    º¹ÇÕü S
  • compound scan motion
    º¹ÇÕ ½ºÄµ ¿îµ¿
  • compound specificity
    È­ÇÕ¹° ƯÀ̼º
  • hydrated compound
    ¼öÈ­ È­ÇÕ¹°
  • impression compound
    Àλó¿ë ÄÞÆÄ¿îµå
    Àλó¿ë°ú Æ®·¹ÀÌ¿ëÀÌ ÀÖ°í, õ¿¬ ¼öÁö, ÇÕ¼º ¼öÁö µîÀ¸·Î µÇ¾î ¿­ °¡¼Ò¼ºÀ» °®´Â ÀλóÀç.
  • inorganic compound
    ¹«±â È­ÇÕ¹°
    ź¼Ò¸¦ Æ÷ÇÔÇÏÁö ¾Ê´Â È­ÇÕ¹°.
  • intermetallic compound
    ±Ý¼Ó°£ È­ÇÕ¹°
    ¼ººÐ ¿ø¼Ò°¡ °£´ÜÇÑ Á¤¼öºñ·Î °áÇÕÇϰí ÀÖ´Â ÇÕ±Ý.
  • modeling compound impression
    ¿¬¼ºÀç Àλó
  • molecular compound
    ºÐÀÚ È­ÇÕ¹°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
cyclic esotropia Periodic convergent strabismus often occurring every 48 hours.
Synonym: alternate day strabismus.
(05 Mar 2000)
cyclic GMP <molecular biology> 3'5' cyclic ester of GMP. A second messenger generated by guanylyl cyclase.
See: ANP, Nitric oxide.
(18 Nov 1997)
cyclic GMP-dependent protein kinases <enzyme> A group of enzymes that are dependent on cyclic GMP and catalyses the phosphorylation of serine or threonine residues of proteins.
Registry number: EC 2.7.10.-
(12 Dec 1998)
cyclic GMP sensitive 3'-exoribonuclease <enzyme> Degradation of newly synthesised RNA in cells of bacillus brevis is mediated primarily by above enzyme
Registry number: EC 3.1.14.-
Synonym: cgmp-exoribonuclease
(26 Jun 1999)
cyclic guanosine monophosphate A cyclic version of the nucleotide guanosine monophosphate. It plays a role in communicating vision from the eyes to the brain.
(09 Oct 1997)
cyclic haematopoiesis An autosomal recessive, inherited immunodeficiency of gray collie dogs characterised by overwhelming recurrent bacterial infections, bleeding, and coat colour dilution.
Synonym: gray collie syndrome.
(05 Mar 2000)
cyclic imp <chemical> Inosine cyclic 3',5'-(hydrogen phosphate). An inosine nucleotide which acts as a mild inhibitor of the hydrolysis of cyclic AMP and cyclic GMP and as an inhibitor of cat heart cyclic AMP phosphodiesterase.
Chemical name: Inosine, cyclic 3',5'-(hydrogen phosphate)
(12 Dec 1998)
cyclic inositol phosphate 1, 2 cyclic derivatives of inositol phosphatide that are invariably formed during enzymic hydrolysis of phosphatidyl inositol species. Have been proposed as second messengers in hormone activated pathways.
(18 Nov 1997)
cyclic neutropenia Neutropenia recurring at regular intervals (14 to 45 days), in association with various types of infectious diseases, e.g., stomatitis, cutaneous ulcers, furuncles, arthritis, and others.
Synonym: cyclic neutropenia.
(05 Mar 2000)
cyclic nucleotide A nucleoside monophosphate in which the phosphoryl group is linked twice to the sugar moiety; e.g., adenosine 3',5'-cyclic monophosphate (cAMP).
(05 Mar 2000)
cyclic nucleotide-regulated protein kinases <enzyme> A group of enzymes that catalyses the phosphorylation of serine or threonine residues of proteins and is dependent on cyclic nucleotides.
Registry number: EC 2.7.10.-
(12 Dec 1998)
cyclic peptide A peptide that forms a ring structure; e.g., tyrocidin A, an antibiotic, is a cyclic decapeptide; valinomycin is a cyclic depsipeptide.
(05 Mar 2000)
cyclic phosphate An activator of phosphorylase kinase and an effector of other enzymes, formed in muscle from ATP by adenylate cyclase and broken down to 5'-AMP by a phosphodiesterase; sometimes referred to as the "second messenger." A related compound (2',3') is also known.
Synonym: cyclic adenylic acid, cyclic AMP, cyclic phosphate.
Acronym: cAMP
(05 Mar 2000)
cyclic phosphoric acid In general, a linear polymer of phosphoric acid residues in pyrophosphate linkage in which the a and &omega; residues are similarly linked to make one endless loop or cyclic compound, specifically, a generic term applied to compounds in which one phosphoric acid residue is esterified to two hydroxyl groups of a single carbon chain, as in adenosine 3',5'-phosphoric acid, adenosine 2',3'-phosphoric acid, etc.
(05 Mar 2000)
cyclic phosphorylation Any process in which a phosphatide ester forms a cylic diester by linkage to a neighbouring hydroxyl group.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • compound interest
    º¹¸®
  • compound interval
    º¹ÇÕÀ½Áú
  • compound leaf
    °ãÀÙ;º¹¿±
  • compound microscope
    º¹ÇÕÇö¹Ì°æ
  • compound number
    Á¦µî¼ö(µÑÀÌ»óÀÇ ´ÜÀ§·Î Ç¥½ÃµÇ´Â ¼ö)
  • compound personal pronoun
    º¹ÇÕ ÀÎĪ ´ë¸í»ç(ÀÎĪ ´ë¸í»ç µÚ¿¡ -self°¡ ºÙÀº °Í)
  • compound relative
    º¹ÇÕ°ü°è»ç
  • compound sentence
    Áß¹®(ÀýÀ» and,butµî µîÀ§ Á¢¼Ó»ç·Î ÀÌÀº ¹®Àå)
  • compound word
    º¹ÇÕ¾î;ÇÕ¼º¾î
  • compound-complex sentence
    Áߺ¹¹®(Á¾¼ÓÀýÀ» ÇϳªÀÌ»ó °¡Áø Áß¹®)
  • interstitia compound
    È­ ħÀÔÇüÈ­ÇÕ¹°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á